UPDATE 1-Teva purchase of Allergan generics business gets OK with conditions

WASHINGTON, July 27 (Reuters) - Teva Pharmaceutical

Industries Ltd won U.S. antitrust approval to purchase

Allergan Plc's generics business, after agreeing to

divest more than 75 generic drugs to rival firms, the Federal

Trade Commission said on Wednesday.

Read more